Jonathan Yingling
Direttore Tecnico/Scientifico/R&S presso ARCUS BIOSCIENCES, INC.
Posizioni attive di Jonathan Yingling
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ARCUS BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2020 | - |
Storia della carriera di Jonathan Yingling
Precedenti posizioni note di Jonathan Yingling
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Direttore Tecnico/Scientifico/R&S | 01/01/2018 | 31/01/2020 |
| Corporate Officer/Principal | 06/02/2017 | 01/01/2018 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/06/2013 | 01/10/2015 |
| DNIB UNWIND INC | Direttore Tecnico/Scientifico/R&S | 16/12/2015 | - |
Formazione di Jonathan Yingling
| Duke University School of Medicine | Doctorate Degree |
| The College of William & Mary | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
- Borsa valori
- Insiders
- Jonathan Yingling
- Esperienza
